BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

0.0739 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioXcel Therapeutics, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Benzinga's Daily Brief On Trending Tickers For April 7, 2022: SDPR S&P 500, Houghton Mifflin, Sunshine Biopharma And More ↗

April 07, 2022

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...

Via Benzinga

4 Top Stock Trades for Thursday: MSFT, TWTR, BTAI, PXD ↗

April 06, 2022

Microsoft, Twitter, BioXcel Therapeutics and Pioneer Natural Resources were our top stock trades for Thursday. Here's the trade now.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 06, 2022

Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 32.4% to $7.43 during Wednesday's regular session. Sunshine Biopharma's stock is trading at a volume of 46.8...

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

April 06, 2022

Gainers Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales...

Via Benzinga

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

Why BioXcel Therapeutics Stock Is Surging Today ↗

April 06, 2022

BioXcel Therapeutics Inc (NASDAQ: BTAI) shares are trading higher Wednesday after the company announced that the U.S. Food and Drug Administration approved IGALMI (...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 06, 2022

Gainers Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 17.5% to $1.35 during Wednesday's pre-market session. The company's market cap stands at $47.6...

Via Benzinga

FDA Approves BioXcel's Igalmi - First Orally Dissolving Sublingual Film For Schizophrenia-Associated Agitation ↗

April 06, 2022

The

Via Benzinga

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy ↗

April 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel ↗

April 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight ↗

April 03, 2022

Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates ↗

April 01, 2022

Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with...

Via Benzinga

Recap: BioXcel Therapeutics Q4 Earnings ↗

March 10, 2022

BioXcel Therapeutics (NASDAQ:BTAI) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer ↗

February 15, 2022

BioXcel Therapeutics Inc (NASDAQ: BTAI) announced results from its ongoing Phase 2 trial of BXCL701 in metastatic castration-resistant prostate cancer (mCRPC) patients with...

Via Benzinga

FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders ↗

December 01, 2021

The FDA has extended the review period for BioXcel Therapeutics Inc's (NASDAQ: BTAI) marketing application seeking approval for BXCL501 for the acute...

Via Benzinga

The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case ↗

December 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir...

Via Benzinga

Topics Intellectual Property

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 01, 2021

Gainers Ardelyx (NASDAQ:ARDX) stock increased by 19.29% to $1.36 during Wednesday's pre-market session. The market value of their outstanding shares is at $153.3...

Via Benzinga

Why BioXcel Therapeutics Is Down Sharply This Week ↗

November 19, 2021

A double downgrade from an analyst on Wall Street is causing investors to think twice about the company's first new drug launch.

Via The Motley Fool

70 Biggest Movers From Yesterday ↗

November 16, 2021

Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...

Via Benzinga

Mid-Afternoon Market Update: Telos Falls After Q3 Results; Creative Realities Shares Spike Higher ↗

November 15, 2021

Toward the end of trading Monday, the Dow traded down 0.05% to 36,082.17 while the NASDAQ fell 0.35% to 15,806.01. The S&P also fell, dropping 0.11% to 4,677.64. The U.S. has...

Via Benzinga

Topics Stocks

Why BioXcel Therapeutics Stock Is Crashing Today ↗

November 15, 2021

An analyst downgraded the stock.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 15, 2021

Gainers Tricida (NASDAQ:TCDA) shares rose...

Via Benzinga

Mid-Day Market Update: Nasdaq Turns Lower; Casper Sleep Shares Jump ↗

November 15, 2021

Midway through trading Monday, the Dow traded up 0.05% to 36,117.49 while the NASDAQ fell 0.29% to 15,815.61. The S&P also fell, dropping 0.06% to 4,679.81. The U.S. has the...

Via Benzinga

Topics Stocks

41 Stocks Moving In Monday's Mid-Day Session ↗

November 15, 2021

Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3...

Via Benzinga

Mid-Morning Market Update: Markets Open Higher; Tyson Foods Posts Upbeat Q4 Results ↗

November 15, 2021

Following the market opening Monday, the Dow traded up 0.27% to 36,196.19 while the NASDAQ rose 0.26% to 15,902.90. The S&P also rose, gaining 0.24% to 4,693.92. The U.S. has...

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021 ↗

November 15, 2021

Upgrades For Targa Resources Corp (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 15, 2021

Gainers EyePoint Pharmaceuticals (NASDAQ:EYPT) stock increased by 44.96% to $20.31 during Monday's pre-market session. The market value of their outstanding shares is...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 15, 2021

Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!

Via InvestorPlace

10 Biggest Price Target Changes For Monday ↗

November 15, 2021

Keybanc boosted the price target on Netflix, Inc. (NASDAQ: NFLX) from $690 to $725. Netflix shares rose 0.2% to $683.90 in pre-market trading. Piper Sandler raised the price...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.